<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="369050">
  <stage>Registered</stage>
  <submitdate>3/08/2015</submitdate>
  <approvaldate>21/08/2015</approvaldate>
  <actrnumber>ACTRN12615000877583</actrnumber>
  <trial_identification>
    <studytitle>In Total Hip Replacement, do ceramic-ceramic or highly-cross-linked plastic bearing surfaces have less migration and wear at 12 years?</studytitle>
    <scientifictitle>In Total Hip Replacement, do ceramic-ceramic or highly-cross-linked plastic bearing surfaces have less migration and wear at 12 years?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total Hip Replacement</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The Reflection 1 or 5 cup (Smith and Nephew) with a porous coating and a cemented Spectron stem (Smith and Nephew) were used in a previous trial. Ceramic-ceramic group received a liner and head of aluminium oxide ceramic. Zhou Z-K, Li MG, Borlin N, Wood DJ, Nivbrant B. No increased migration in cups with ceramic-on-ceramic bearing: An RSA study. Clin Orthop Relat Res. 2006; 448: 39-45.</interventions>
    <comparator>Acetabular highly cross-linked plastic bearing. This group received a metal (cobalt chromium) head and a highly cross-linked plastic liner. </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Wear rates via RSA migration
</outcome>
      <timepoint>12 years post-surgery</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Revision rates (collated from patient enquiry and review of medical records)</outcome>
      <timepoint>12 years post-surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Hip joint function (Harris Hip Score, WOMAC Hip score)</outcome>
      <timepoint>12 years post-surgery</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Follow-up study. Invite to participants of a previous RCT. This study had inclusion of primary total hip replacement for osteoarthritis. Participants were recruited from the waitlist of  2 senior orthopaedic surgeons.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Unable to provide informed consent
Unable to participate travel for radiological assessment
Deceased</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation was not concealed</concealment>
    <sequence>Computer-generated sequence</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Due to the high precision of RSA, excessively migrating prostheses can be discriminated, and failure predicted, using only a small sample size: about 1525 patients (Valstar et al. 2005)</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/09/2015</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>61</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Withdrawn</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason>Other reasons/comments</withdrawnreason>
    <withdrawnreasonother>study terminated, ethics approved one site pending approval at another which was not approved
</withdrawnreasonother>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>WA</recruitmentstate>
    <hospital>Hollywood Private Hospital - Nedlands</hospital>
    <hospital>Sir Charles Gairdner Hospital - Nedlands</hospital>
    <postcode>6009 - Broadway Nedlands</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>The Joint Studio</primarysponsorname>
    <primarysponsoraddress>1/ 85 Monash Ave, Nedlands WA 6019</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>The Joint Studio</fundingname>
      <fundingaddress>Hollywood Medical Centre
1/ 85 Monash Ave, Nedlands WA 6009</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Hollywood Private Hospital</sponsorname>
      <sponsoraddress>Monash Ave, Nedlands WA 6009</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We propose to follow up 61 participants from a previous randomized controlled trial conducted in 2001-2002 at SCGH and Hollywood Private Hospital, which randomized participants for total hip replacement to either a ceramic-ceramic or metal-highly-crosslinked-plastic bearing surface. The 12-year outcomes, in terms of radiographically measured wear rate and implant migration, and clinical findings will be determined and presented for each group.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Submitted, not yet approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Hollywood Private Hospital ethics committee</ethicname>
      <ethicaddress>Hollywood Private Hospital, Monash Ave, Nedlands</ethicaddress>
      <ethicapprovaldate>10/07/2015</ethicapprovaldate>
      <hrec>HPH417</hrec>
      <ethicsubmitdate>30/04/2015</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Dan Fick</name>
      <address>The Joint Studio
1/ 85 Monash Ave, Nedlands WA 6009</address>
      <phone>+61 8 93863933</phone>
      <fax />
      <email>research@thejointstudio.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Samantha Haebich</name>
      <address>The Joint Studio
1/ 85 Monash Ave, Nedlands WA 6009</address>
      <phone>+61 8 93863933</phone>
      <fax />
      <email>research@thejointstudio.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Samantha Haebich</name>
      <address>The Joint Studio
1/ 85 Monash Ave, Nedlands WA 6009</address>
      <phone>+61 8 93863933</phone>
      <fax />
      <email>research@thejointstudio.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>